Gene: XRRA1
Official Full Name: X-ray radiation resistance associated 1provided by HGNC
Gene Summary: Involved in response to X-ray. Located in cytoplasm and nuclear body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24171 | XRRA1 Knockout cell line (HeLa) | Human | XRRA1 | 1:3~1:6 | Negative | Online Inquiry |
KO24172 | XRRA1 Knockout cell line (HCT 116) | Human | XRRA1 | 1:2~1:4 | Negative | Online Inquiry |
KO24173 | XRRA1 Knockout cell line (A549) | Human | XRRA1 | 1:3~1:4 | Negative | Online Inquiry |
XRRA1 Gene Knockout Cell Lines represent a groundbreaking biotechnological advancement designed for researchers studying gene function and therapeutic interventions. These engineered cell lines have undergone precise genetic modifications, specifically targeting the XRRA1 gene, which plays a crucial role in various cellular processes, including gene regulation and response to stress. By knocking out this gene, researchers can elucidate its biological significance, investigate downstream effects, and assess potential compensatory mechanisms within the cellular environment.
The primary function of the XRRA1 Gene Knockout Cell Lines is to provide an in vitro model that allows scientists to dissect the roles of the XRRA1 gene in various biological contexts, such as cellular signaling, apoptosis, and developmental biology. This cell line is particularly beneficial for drug screening and functional genomics, enabling studies that require a controlled setting to understand the nuances of gene interaction and regulation.
Scientifically, the availability of XRRA1 knockout models is invaluable, especially in research related to cancer biology, neurobiology, and therapeutic drug development. These models enable the assessment of gene-editing technologies, such as CRISPR/Cas9 applications, revealing the potential effects of genetic modifications on cell survival and proliferation. The data generated from these studies can subsequently inform clinical strategies aimed at targeting XRRA1-related pathways in disease contexts.
What sets our XRRA1 Gene Knockout Cell Lines apart from traditional cell models is their specificity and reliability, coupled with a robust genetic background, ensuring reproducibility across experiments. Unlike other systems that may yield inconsistent results due to genetic heterogeneity, our cell lines offer a stable and well-characterized environment, making them indispensable tools for high-precision research.
For researchers and clinicians striving to advance the frontiers of genetics and cellular biology, XRRA1 Gene Knockout Cell Lines provide a unique opportunity to explore new therapeutic avenues and enhance our understanding of gene-coupled diseases. By supporting innovative research and translational applications, our commitment to quality and cutting-edge technology ensures that our products continuously meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.